Related Experiment Video

Updated: May 15, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Anticoagulation in patients with dilated cardiomyopathy, low ejection fraction, and sinus rhythm: back to the drawing

Alexandru Nicolae Mischie1, Valentin Chioncel, Ionel Droc

  • 1Cardiology Department, "Bagdasar Arseni" Emergency Hospital, Bucharest, Romania.

Cardiovascular Therapeutics
|January 3, 2013
PubMed

Insights

Heart failure patients face high thrombo-embolic risks. Novel anticoagulants offer a promising alternative to warfarin and aspirin, potentially improving efficacy while reducing bleeding complications.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Heart failure patients, particularly those in sinus rhythm with reduced ejection fraction (<35%), have a significant risk of thrombo-embolic events like stroke.
  • Previous anticoagulation trials (e.g., WATCH, WARCEF) using warfarin versus aspirin showed marginal benefits but increased major hemorrhage risks.
  • There is a need for safer and more effective anticoagulation strategies in this high-risk patient population.

Purpose of the Study:

  • To evaluate the potential of novel oral anticoagulants (NOACs) as a safer and more effective alternative for thrombo-embolic risk reduction in heart failure patients.
  • To address the limitations of existing anticoagulation therapies, including suboptimal efficacy and bleeding concerns.

Main Methods:

  • Review of prospective randomized trials and existing literature on anticoagulation in heart failure patients.
  • Analysis of data comparing warfarin, aspirin, and novel anticoagulants (dabigatran, rivaroxaban, apixaban).

Main Results:

  • Warfarin showed a slight advantage over aspirin in some trials but was associated with a higher risk of major bleeding.
  • Novel anticoagulants demonstrate promise as a potentially more effective and safer alternative, balancing anticoagulant effect with reduced bleeding rates.

Conclusions:

  • Novel anticoagulants represent a promising therapeutic strategy for managing thrombo-embolic risk in heart failure patients.
  • Further research and clinical trials are warranted to fully establish the role of NOACs in this population, focusing on efficacy and safety profiles.

Keywords:
ApixabanDabigatranDilated cardiomyopathyHeart failureLow ejection fraction <35%RivaroxabanSinus rhythm

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...